Understanding the root cause BPC-157 is being explored for its potential applications in musculoskeletal healing, inflammation control and gut health support
So we don't even know what that is
TB-500 has a 710 day half-life allowing flexible timing, while BPC-157s shorter half-life (several hours) traditionally led researchers to dose twice daily for sustained levels
Less Frequent Dosing: Instead of a daily pill, injections are typically given on a weekly or monthly schedule as determined by a healthcare provider
Tang N, Zhang W, Su Y, Han Z, Deng L, Li Y, Huang T, Li C
Clinical Evidence for Skin Rejuvenation The evidence base for GHK-Cu spans over four decades of research, including multiple human clinical trials specifically examining skin rejuvenation effects